{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:37:02Z","timestamp":1792791422772,"version":"4.5.0"},"reference-count":144,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRU 303"],"award-info":[{"award-number":["CRU 303"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.autrev.2021.102852","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T12:42:35Z","timestamp":1620391355000},"page":"102852","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["MicroRNAs in pemphigus and pemphigoid diseases"],"prefix":"10.1016","volume":"20","author":[{"given":"Cristian","family":"Papara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian D.","family":"Sadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Baican","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2021.102852_bb0005","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(19)31778-7","article-title":"Pemphigus","volume":"394","author":"Schmidt","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102852_bb0010","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0140-6736(12)61140-4","article-title":"Pemphigoid diseases","volume":"381","author":"Schmidt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.autrev.2021.102852_bb0015","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2174\/15665240113136660079","article-title":"Molecular diagnosis in autoimmune skin blistering conditions","volume":"14","author":"Otten","year":"2014","journal-title":"Curr Mol Med"},{"key":"10.1016\/j.autrev.2021.102852_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-017-8662-z","article-title":"Pemphigus: a comprehensive review on pathogenesis, clinical presentation and novel therapeutic approaches","volume":"54","author":"Pollmann","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0025","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00281-019-00759-y","article-title":"Resolution in bullous pemphigoid","volume":"41","author":"Sadik","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.autrev.2021.102852_bb0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0035","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating MicroRNAs in Cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"10.1016\/j.autrev.2021.102852_bb0040","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.autrev.2016.09.003","article-title":"The role of microRNAs in the pathogenesis of autoimmune diseases","volume":"15","author":"Chen","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102852_bb0045","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1684\/ejd.2017.3024","article-title":"MicroRNA in skin diseases","volume":"27","author":"Ruksha","year":"2017","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0050","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1101\/gr.082701.108","article-title":"Most mammalian mRNAs are conserved targets of microRNAs","volume":"19","author":"Friedman","year":"2008","journal-title":"Genome Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0055","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1146\/annurev-biochem-060308-103103","article-title":"Regulation of mRNA translation and stability by microRNAs","volume":"79","author":"Fabian","year":"2010","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.autrev.2021.102852_bb0060","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41580-018-0059-1","article-title":"Regulation of microRNA biogenesis and its crosstalk with other cellular pathways","volume":"20","author":"Treiber","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.autrev.2021.102852_bb0065","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O\u2019Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.autrev.2021.102852_bb0070","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.metabol.2012.04.009","article-title":"MicroRNA regulation of lipid metabolism","volume":"62","author":"Flowers","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/j.autrev.2021.102852_bb0075","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ni.f.209","article-title":"MicroRNAs: new regulators of immune cell development and function","volume":"9","author":"Baltimore","year":"2008","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.dci.2017.08.001","article-title":"Immunomodulation: a definitive role of microRNA-142","volume":"77","author":"Sharma","year":"2017","journal-title":"Dev Comp Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0085","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/j.molmed.2014.06.005","article-title":"MicroRNAs in cancer: biomarkers, functions and therapy","volume":"20","author":"Hayes","year":"2014","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.autrev.2021.102852_bb0090","doi-asserted-by":"crossref","first-page":"15004","DOI":"10.1038\/sigtrans.2015.4","article-title":"The role of MicroRNAs in human cancer","volume":"1","author":"Peng","year":"2016","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.autrev.2021.102852_bb0095","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.canlet.2018.04.016","article-title":"Dysregulation of microRNAs in autoimmune diseases: pathogenesis, biomarkers and potential therapeutic targets","volume":"428","author":"Long","year":"2018","journal-title":"Cancer Lett"},{"key":"10.1016\/j.autrev.2021.102852_bb0100","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08916934.2019.1710135","article-title":"Identifying the differentially expressed microRNAs in autoimmunity: a systemic review and meta-analysis","volume":"53","author":"Zhang","year":"2020","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2021.102852_bb0105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1111\/exd.13249","article-title":"Roles of microRNAs in psoriasis: immunological functions and potential biomarkers","volume":"26","author":"Liu","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0110","article-title":"MicroRNA analysis of childhood atopic dermatitis reveals a role for miR-451a","author":"Nousbeck","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0115","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-019-01991-0","article-title":"MicroRNA in localized scleroderma: a review of literature","volume":"312","author":"Wolska-Gawron","year":"2020","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0120","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.3892\/mmr.2017.6422","article-title":"Increased miR-424-5p expression in peripheral blood mononuclear cells from patients with pemphigus","volume":"15","author":"Wang","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2021.102852_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/9505312","article-title":"miR-1291 functions as a potential serum biomarker for bullous Pemphigoid","volume":"2020","author":"Qiu","year":"2020","journal-title":"Dis Markers"},{"key":"10.1016\/j.autrev.2021.102852_bb0130","doi-asserted-by":"crossref","first-page":"5692","DOI":"10.1093\/nar\/gkr148","article-title":"Analysis of microRNA turnover in mammalian cells following Dicer1 ablation","volume":"39","author":"Gantier","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0135","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1002\/1878-0261.12144","article-title":"Cell-to-cell communication: microRNAs as hormones","volume":"11","author":"Bayraktar","year":"2017","journal-title":"Mol Oncol"},{"key":"10.1016\/j.autrev.2021.102852_bb0140","series-title":"Multiple pathways mediate MicroRNA degradation: focus on the translin\/Trax RNase complex","first-page":"1","author":"Baraban","year":"2018"},{"key":"10.1016\/j.autrev.2021.102852_bb0145","doi-asserted-by":"crossref","first-page":"4051","DOI":"10.1038\/sj.emboj.7600385","article-title":"MicroRNA genes are transcribed by RNA polymerase II","volume":"23","author":"Lee","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2021.102852_bb0150","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1093\/emboj\/cdf476","article-title":"MicroRNA maturation: stepwise processing and subcellular localization","volume":"21","author":"Lee","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.autrev.2021.102852_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature01957","article-title":"The nuclear RNase III Drosha initiates microRNA processing","volume":"425","author":"Lee","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102852_bb0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nature03120","article-title":"The microprocessor complex mediates the genesis of microRNAs","volume":"432","author":"Gregory","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102852_bb0165","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1101\/gad.1158803","article-title":"Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs","volume":"17","author":"Yi","year":"2003","journal-title":"Genes Dev"},{"key":"10.1016\/j.autrev.2021.102852_bb0170","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nature10198","article-title":"Dicer recognizes the 5\u2032 end of RNA for efficient and accurate processing","volume":"475","author":"Park","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.autrev.2021.102852_bb0175","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.molcel.2004.07.007","article-title":"Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs","volume":"15","author":"Meister","year":"2004","journal-title":"Mol Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0180","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.celrep.2013.09.029","article-title":"Poly(a)-specific Ribonuclease mediates 3\u2032-end trimming of Argonaute2-cleaved precursor MicroRNAs","volume":"5","author":"Yoda","year":"2013","journal-title":"Cell Rep"},{"key":"10.1016\/j.autrev.2021.102852_bb0185","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are MicroRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0190","first-page":"71","article-title":"RISC assembly: coordination between small RNAs and Argonaute proteins","volume":"2016","author":"Kobayashi","year":"1859","journal-title":"Biochim Biophys Acta - Gene Regul Mech"},{"key":"10.1016\/j.autrev.2021.102852_bb0195","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1101\/gad.1399806","article-title":"Control of translation and mRNA degradation by miRNAs and siRNAs","volume":"20","author":"Valencia-Sanchez","year":"2006","journal-title":"Genes Dev"},{"key":"10.1016\/j.autrev.2021.102852_bb0200","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.biopha.2018.09.090","article-title":"MicroRNAs as biological regulators in skin disorders","volume":"108","author":"Singhvi","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.autrev.2021.102852_bb0205","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.tcb.2006.12.007","article-title":"Repression of protein synthesis by miRNAs: how many mechanisms?","volume":"17","author":"Pillai","year":"2007","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.autrev.2021.102852_bb0210","doi-asserted-by":"crossref","first-page":"7560","DOI":"10.1038\/s41598-018-25578-3","article-title":"Distinguishing mirtrons from canonical miRNAs with data exploration and machine learning methods","volume":"8","author":"Rorbach","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.102852_bb0215","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/bjd.12630","article-title":"Prognostic factors in pemphigus vulgaris and pemphigus foliaceus","volume":"170","author":"Saha","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0220","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jaad.2015.10.051","article-title":"Immunologic prediction of relapse in patients with pemphigus vulgaris (PV) in clinical remission","volume":"74","author":"Daneshpazhooh","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0225","doi-asserted-by":"crossref","first-page":"23778","DOI":"10.1074\/jbc.M501365200","article-title":"Desmosome Signaling","volume":"280","author":"Berkowitz","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102852_bb0230","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.yexcr.2009.10.005","article-title":"Induction of hyper-adhesion attenuates autoimmune-induced keratinocyte cell\u2013cell detachment and processing of adhesion molecules via mechanisms that involve PKC","volume":"316","author":"Cirillo","year":"2010","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0235","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/sj.jid.5701080","article-title":"Induction of p38MAPK and HSP27 phosphorylation in pemphigus patient skin","volume":"128","author":"Berkowitz","year":"2008","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0240","doi-asserted-by":"crossref","first-page":"12855","DOI":"10.1073\/pnas.0602973103","article-title":"p38MAPK inhibition prevents disease in pemphigus vulgaris mice","volume":"103","author":"Berkowitz","year":"2006","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.autrev.2021.102852_bb0245","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/08916930600971943","article-title":"Pathogenic monoclonal antibody against desmoglein 3 augments desmoglein 3 and p38 MAPK phosphorylation in human squamous carcinoma cell line","volume":"39","author":"Kawasaki","year":"2006","journal-title":"Autoimmunity"},{"key":"10.1016\/j.autrev.2021.102852_bb0250","doi-asserted-by":"crossref","first-page":"12524","DOI":"10.1074\/jbc.M808204200","article-title":"Biphasic activation of p38MAPK suggests that apoptosis is a downstream event in pemphigus Acantholysis","volume":"284","author":"Lee","year":"2009","journal-title":"J Biol Chem"},{"key":"10.1016\/j.autrev.2021.102852_bb0255","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00692","article-title":"Autoantibody signaling in pemphigus vulgaris: development of an integrated model","volume":"9","author":"Sajda","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0260","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/jid.2013.224","article-title":"MAPKAP kinase 2 (MK2)-dependent and -independent models of blister formation in pemphigus vulgaris","volume":"134","author":"Mao","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0265","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1128\/MCB.15.1.505","article-title":"Modulation of cellular thermoresistance and actin filament stability accompanies phosphorylation-induced changes in the oligomeric structure of heat shock protein 27","volume":"15","author":"Lavoie","year":"1995","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.autrev.2021.102852_bb0270","article-title":"Increased expression of microRNA-338-3p contributes to production of Dsg3 antibody in pemphigus vulgaris patients","author":"Liu","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.autrev.2021.102852_bb0275","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5388","article-title":"Usefulness of miRNA-338-3p in the diagnosis of pemphigus and its correlation with disease severity","volume":"6","author":"Lin","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.autrev.2021.102852_bb0280","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4161\/cc.11.5.19300","article-title":"The role of TRADD in death receptor signaling","volume":"11","author":"Pobezinskaya","year":"2012","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2021.102852_bb0285","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/ni.1714","article-title":"Death receptor signal transducers: nodes of coordination in immune signaling networks","volume":"10","author":"Wilson","year":"2009","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0290","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1111\/j.1600-065X.2011.01068.x","article-title":"TL1A and DR3, a TNF family ligand-receptor pair that promotes lymphocyte costimulation, mucosal hyperplasia, and autoimmune inflammation","volume":"244","author":"Meylan","year":"2011","journal-title":"Immunol Rev"},{"key":"10.1016\/j.autrev.2021.102852_bb0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00583","article-title":"TL1A (TNFSF15) and DR3 (TNFRSF25): a co-stimulatory system of cytokines with diverse functions in gut mucosal immunity","volume":"10","author":"Valatas","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0300","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/mi.2010.67","article-title":"The TNF-family cytokine TL1A drives IL-13-dependent small intestinal inflammation","volume":"4","author":"Meylan","year":"2011","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0305","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1084\/jem.20071364","article-title":"TL1A\u2013DR3 interaction regulates Th17 cell function and Th17-mediated autoimmune disease","volume":"205","author":"Pappu","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2021.102852_bb0310","article-title":"Tumor necrosis factor\u2013like cytokine TL1A and its receptors DR3 and DcR3","volume":"1","author":"Siakavellas","year":"2015","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.autrev.2021.102852_bb0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semarthrit.2015.02.007","article-title":"The TL1A\/DR3\/DcR3 pathway in autoimmune rheumatic diseases","volume":"45","author":"Siakavellas","year":"2015","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2021.102852_bb0320","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1600-0625.2011.01304.x","article-title":"Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions","volume":"20","author":"Bamias","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0325","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1080\/08820130902943097","article-title":"Involvement of T H 1\/T H 2 cytokines in the pathogenesis of autoimmune skin disease\u2014 pemphigus vulgaris","volume":"38","author":"Satyam","year":"2009","journal-title":"Immunol Invest"},{"key":"10.1016\/j.autrev.2021.102852_bb0330","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1172\/JCI28547","article-title":"T cell control in autoimmune bullous skin disorders","volume":"116","author":"Hertl","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.autrev.2021.102852_bb0335","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148919","article-title":"Increased frequency of T follicular helper cells and elevated Interleukin-27 plasma levels in patients with pemphigus","volume":"11","author":"Hennerici","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102852_bb0340","doi-asserted-by":"crossref","first-page":"e1399","DOI":"10.1038\/cddis.2014.366","article-title":"The RING ubiquitin E3 RNF114 interacts with A20 and modulates NF-\u03baB activity and T-cell activation","volume":"5","author":"Rodriguez","year":"2014","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.autrev.2021.102852_bb0345","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.imbio.2014.02.002","article-title":"Identification of RNF114 as a novel positive regulatory protein for T cell activation","volume":"219","author":"Yang","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.autrev.2021.102852_bb0350","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/imm.12315","article-title":"Genome-wide gene expression profiling reveals unsuspected molecular alterations in pemphigus foliaceus","volume":"143","author":"Malheiros","year":"2014","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2021.102852_bb0355","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1002\/eji.200838690","article-title":"Interaction of KLRG1 with E-cadherin: new functional and structural insights","volume":"38","author":"Rosshart","year":"2008","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0360","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.4049\/jimmunol.176.3.1311","article-title":"Cutting edge: identification of E-cadherin as a ligand for the murine killer cell Lectin-like receptor G1","volume":"176","author":"Gr\u00fcndemann","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0365","doi-asserted-by":"crossref","first-page":"5299","DOI":"10.1182\/blood-2009-06-228353","article-title":"Immunoregulatory functions of KLRG1 cadherin interactions are dependent on forward and reverse signaling","volume":"114","author":"Banh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2021.102852_bb0370","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tcb.2004.07.007","article-title":"The ins and outs of E-cadherin trafficking","volume":"14","author":"Bryant","year":"2004","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.autrev.2021.102852_bb0375","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1111\/j.1346-8138.1994.tb03294.x","article-title":"Cadherins in cutaneous biology","volume":"21","author":"Furukawa","year":"1994","journal-title":"J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0380","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1242\/jcs.066654","article-title":"Classical and desmosomal cadherins at a glance","volume":"125","author":"Saito","year":"2012","journal-title":"J Cell Sci"},{"key":"10.1016\/j.autrev.2021.102852_bb0385","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/j.1600-0625.2009.00934.x","article-title":"Apoptolysis: a novel mechanism of skin blistering in pemphigus vulgaris linking the apoptotic pathways to basal cell shrinkage and suprabasal acantholysis","volume":"18","author":"Grando","year":"2009","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0390","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1038\/jid.2012.232","article-title":"IgG autoantibody response against keratinocyte Cadherins in endemic pemphigus Foliaceus (Fogo Selvagem)","volume":"132","author":"Flores","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0395","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bjd.12455","article-title":"E-cadherin autoantibody profile in patients with pemphigus vulgaris","volume":"169","author":"Oliveira","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057587","article-title":"Pemphigus vulgaris autoantibody profiling by proteomic technique","volume":"8","author":"Kalantari-Dehaghi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102852_bb0405","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/1523-1747.ep12274679","article-title":"Experimentally induced pemphigus vulgaris in neonatal BALB\/c mice: a time-course study of clinical, immunologic, Ultrastructural, and Cytochemical changes","volume":"84","author":"Takahashi","year":"1985","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0410","first-page":"1306","article-title":"A 3\u2032UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility","volume":"2016","author":"Cipolla","year":"1859","journal-title":"Biochim Biophys Acta - Gene Regul Mech"},{"key":"10.1016\/j.autrev.2021.102852_bb0415","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.ceca.2007.06.005","article-title":"Hailey\u2013Hailey disease from a clinical perspective","volume":"43","author":"Kellermayer","year":"2008","journal-title":"Cell Calcium"},{"key":"10.1016\/j.autrev.2021.102852_bb0420","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/71701","article-title":"Mutations in ATP2C1, encoding a calcium pump, cause Hailey-Hailey disease","volume":"24","author":"Hu","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.autrev.2021.102852_bb0425","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1091\/mbc.9.5.1149","article-title":"The medial -Golgi ion pump Pmr1 supplies the yeast secretory pathway with Ca 2+ and Mn 2+ required for glycosylation, sorting, and endoplasmic reticulum-associated protein degradation","volume":"9","author":"D\u00fcrr","year":"1998","journal-title":"Mol Biol Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0430","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1046\/j.1523-1747.2003.12528.x","article-title":"Human keratinocyte ATP2C1 localizes to the Golgi and controls Golgi Ca2+ stores","volume":"121","author":"Behne","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0435","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1600-0625.2011.01359.x","article-title":"Oxidative stress activation of miR-125b is part of the molecular switch for Hailey-Hailey disease manifestation","volume":"20","author":"Manca","year":"2011","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0440","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2133.2009.09500.x","article-title":"Complex multipathways alterations and oxidative stress are associated with Hailey-Hailey disease","volume":"162","author":"Cialfi","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0445","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/1523-1747.ep12613469","article-title":"Pemphigus IgG, but not bullous Pemphigoid IgG, causes a transient increase in intracellular calcium and inositol 1,4,5-triphosphate in DJM-1 cells, a squamous cell carcinoma line","volume":"104","author":"Seishima","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0450","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1007\/s00018-008-8119-x","article-title":"p63 in epithelial development","volume":"65","author":"Candi","year":"2008","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.autrev.2021.102852_bb0455","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1101\/gad.1190504","article-title":"p63 and the epithelial stem cell: more than status quo?","volume":"18","author":"McKeon","year":"2004","journal-title":"Genes Dev"},{"key":"10.1016\/j.autrev.2021.102852_bb0460","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.4161\/cc.5.16.2861","article-title":"Itch\/AIP4 associates with and promotes p63 protein degradation","volume":"5","author":"Rossi","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2021.102852_bb0465","doi-asserted-by":"crossref","first-page":"873","DOI":"10.4161\/cc.4.7.1836","article-title":"A new Perp in the lineup: linking p63 and Desmosomal adhesion","volume":"4","author":"Ihrie","year":"2005","journal-title":"Cell Cycle"},{"key":"10.1016\/j.autrev.2021.102852_bb0470","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.cell.2005.01.008","article-title":"Perp is a p63-regulated gene essential for epithelial integrity","volume":"120","author":"Ihrie","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0475","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.3112re3","article-title":"Stress-activated cap\u2019n\u2019collar transcription factors in aging and human disease","volume":"3","author":"Sykiotis","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.autrev.2021.102852_bb0480","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tox.2007.10.029","article-title":"The Nrf2\u2013Keap1 defence pathway: role in protection against drug-induced toxicity","volume":"246","author":"Copple","year":"2008","journal-title":"Toxicology"},{"key":"10.1016\/j.autrev.2021.102852_bb0485","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/emmm.201200219","article-title":"Nrf2 links epidermal barrier function with antioxidant defense","volume":"4","author":"Sch\u00e4fer","year":"2012","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.autrev.2021.102852_bb0490","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1038\/ncomms6099","article-title":"A novel Nrf2-miR-29-desmocollin-2 axis regulates desmosome function in keratinocytes","volume":"5","author":"Kurinna","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.autrev.2021.102852_bb0495","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/exd.13409","article-title":"Routine detection of serum antidesmocollin autoantibodies is only useful in patients with atypical pemphigus","volume":"26","author":"Mindorf","year":"2017","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0500","first-page":"598","article-title":"Clinical and immunopathological spectrum of paraneoplastic pemphigus","volume":"8","author":"Zimmermann","year":"2010","journal-title":"JDDG J Der Dtsch Dermatologischen Gesellschaft"},{"key":"10.1016\/j.autrev.2021.102852_bb0505","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1016\/j.jid.2016.05.115","article-title":"miR-29 regulates type VII collagen in recessive dystrophic Epidermolysis Bullosa","volume":"136","author":"Vanden Oever","year":"2016","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0510","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1167\/iovs.11-8670","article-title":"Suppression of type I collagen expression by miR-29b via PI3K, Akt, and Sp1 pathway in human Tenon\u2019s fibroblasts","volume":"53","author":"Li","year":"2012","journal-title":"Investig Opthalmology Vis Sci"},{"key":"10.1016\/j.autrev.2021.102852_bb0515","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.matbio.2018.04.001","article-title":"Epidermolysis bullosa: molecular pathology of connective tissue components in the cutaneous basement membrane zone","volume":"71\u201372","author":"Has","year":"2018","journal-title":"Matrix Biol"},{"key":"10.1016\/j.autrev.2021.102852_bb0520","article-title":"Inhibition of miR-29 by TGF-beta-Smad3 signaling through dual mechanisms promotes Transdifferentiation of mouse myoblasts into Myofibroblasts","volume":"7","author":"Zhou","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2021.102852_bb0525","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/bjd.17640","article-title":"Long noncoding RNA polymorphisms influence susceptibility to endemic pemphigus foliaceus","volume":"181","author":"Lobo-Alves","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0530","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/imm.13003","article-title":"Screening the full leucocyte receptor complex genomic region revealed associations with pemphigus that might be explained by gene regulation","volume":"156","author":"Farias","year":"2019","journal-title":"Immunology"},{"key":"10.1016\/j.autrev.2021.102852_bb0535","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1016\/j.cell.2013.02.012","article-title":"Long noncoding RNAs: cellular address codes in development and disease","volume":"152","author":"Batista","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0540","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev-biochem-051410-092902","article-title":"Genome regulation by Long noncoding RNAs","volume":"81","author":"Rinn","year":"2012","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.autrev.2021.102852_bb0545","doi-asserted-by":"crossref","first-page":"3965","DOI":"10.1158\/0008-5472.CAN-16-2634","article-title":"Long noncoding RNA and Cancer: a new paradigm","volume":"77","author":"Bhan","year":"2017","journal-title":"Cancer Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0550","doi-asserted-by":"crossref","DOI":"10.4110\/in.2019.19.e4","article-title":"Potential implications of Long noncoding RNAs in autoimmune diseases","volume":"19","author":"Hur","year":"2019","journal-title":"Immune Netw"},{"key":"10.1016\/j.autrev.2021.102852_bb0555","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aad0467","article-title":"A long noncoding RNA associated with susceptibility to celiac disease","volume":"352","author":"Castellanos-Rubio","year":"2016","journal-title":"Science (80)"},{"key":"10.1016\/j.autrev.2021.102852_bb0560","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.ajhg.2016.03.025","article-title":"Polymorphism in a lincRNA associates with a doubled risk of pneumococcal bacteremia in Kenyan children","volume":"98","author":"Rautanen","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.autrev.2021.102852_bb0565","doi-asserted-by":"crossref","DOI":"10.1111\/exd.14275","article-title":"Genetic variability of immune-related lncRNAs: polymorphisms in LINC-PINT and LY86-AS1 are associated with pemphigus foliaceus susceptibility","author":"Salviano-Silva","year":"2021","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0570","article-title":"circlncRNAnet: An integrated web-based resource for mapping functional networks of long or circular forms of non-coding RNAs","author":"Wu","year":"2017","journal-title":"Gigascience"},{"key":"10.1016\/j.autrev.2021.102852_bb0575","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41598-018-19226-z","article-title":"Dysfunction of CD19+CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid","volume":"8","author":"Liu","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.autrev.2021.102852_bb0580","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/j.1365-2249.2004.02570.x","article-title":"Interleukin-16 expression and release in bullous pemphigoid","volume":"137","author":"FREZZOLINI","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0585","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1759720X17735756","article-title":"Anti-interleukin and interleukin therapies for psoriasis: current evidence and clinical usefulness","volume":"9","author":"Tsai","year":"2017","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/j.autrev.2021.102852_bb0590","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2006.02.045","article-title":"A Rich1\/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells","volume":"125","author":"Wells","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.autrev.2021.102852_bb0595","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1111\/jdv.15679","article-title":"Review of autoimmune blistering diseases: the Pemphigoid diseases","volume":"33","author":"Daniel","year":"2019","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2021.102852_bb0600","doi-asserted-by":"crossref","unstructured":"Genovese G, Di Zenzo G, Cozzani E, Berti E, Cugno M, Marzano AV. New insights into the pathogenesis of bullous pemphigoid: 2019 update. Front Immunol 2019;10. doi:https:\/\/doi.org\/10.3389\/fimmu.2019.01506.","DOI":"10.3389\/fimmu.2019.01506"},{"key":"10.1016\/j.autrev.2021.102852_bb0605","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.02687","article-title":"Complement-activating capacity of autoantibodies correlates with disease activity in bullous Pemphigoid patients","volume":"9","author":"Chiorean","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0610","first-page":"1077","article-title":"Diagnosis of autoimmune bullous diseases","volume":"16","author":"van Beek","year":"2018","journal-title":"JDDG J Der Dtsch Dermatologischen Gesellschaft"},{"key":"10.1016\/j.autrev.2021.102852_bb0615","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1046\/j.0022-202x.2001.01505.x","article-title":"Skin-homing Interleukin-4 and -13-producing cells contribute to bullous Pemphigoid: remission of disease is associated with increased frequency of Interleukin-10-producing cells","volume":"117","author":"Teraki","year":"2001","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0620","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.02331","article-title":"The intersection of IgE autoantibodies and eosinophilia in the pathogenesis of bullous Pemphigoid","volume":"10","author":"Messingham","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0625","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/BF02507102","article-title":"Detection of elevated levels of IL-4, IL-6, and IL-10 in blister fluid of bullous pemphigoid","volume":"288","author":"Schmidt","year":"1996","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.autrev.2021.102852_bb0630","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1365-2133.2003.05066.x","article-title":"High level of thymus and activation-regulated chemokine in blister fluid and sera of patients with bullous pemphigoid","volume":"148","author":"Kakinuma","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0635","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/jdv.12719","article-title":"Serum thymus and activation-regulated chemokine (TARC\/CCL17) levels reflect the disease activity in a patient with bullous pemphigoid","volume":"30","author":"Nin-Asai","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.autrev.2021.102852_bb0640","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.clim.2006.03.014","article-title":"Increased expression of Th2-associated chemokines in bullous pemphigoid disease. Role of eosinophils in the production and release of these chemokines","volume":"120","author":"Gounni Abdelilah","year":"2006","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0645","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.immuni.2012.03.014","article-title":"JAK and STAT signaling molecules in Immunoregulation and immune-mediated disease","volume":"36","author":"O\u2019Shea","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.autrev.2021.102852_bb0650","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mrfmmm.2010.01.017","article-title":"Genetic factors in chronic inflammation: single nucleotide polymorphisms in the STAT-JAK pathway, susceptibility to DNA damage and Crohn\u2019s disease in a New Zealand population","volume":"690","author":"Ferguson","year":"2010","journal-title":"Mutat Res Mol Mech Mutagen"},{"key":"10.1016\/j.autrev.2021.102852_bb0655","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1136\/ard.2006.060822","article-title":"Characterisation of a dendritic cell subset in synovial tissue which strongly expresses Jak\/STAT transcription factors from patients with rheumatoid arthritis","volume":"66","author":"Walker","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2021.102852_bb0660","doi-asserted-by":"crossref","first-page":"198","DOI":"10.12788\/j.sder.2018.041","article-title":"JAK-STAT signaling pathway inhibition: a role for treatment of various dermatologic diseases","volume":"37","author":"Kahn","year":"2018","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.autrev.2021.102852_bb0665","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1016\/j.jaci.2018.03.014","article-title":"Regulatory T-cell dysfunction induces autoantibodies to bullous pemphigoid antigens in mice and human subjects","volume":"142","author":"Muramatsu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0670","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2017\/6716419","article-title":"Expression of the JAK\/STAT signaling pathway in bullous Pemphigoid and dermatitis Herpetiformis","volume":"2017","author":"Juczynska","year":"2017","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.autrev.2021.102852_bb0675","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1400063","article-title":"Tofacitinib suppresses antibody responses to protein therapeutics in murine hosts","volume":"193","author":"Onda","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0680","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92253","article-title":"Stat3 regulates desmoglein 3 transcription in epithelial keratinocytes","volume":"2","author":"Mao","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.autrev.2021.102852_bb0685","first-page":"S16","article-title":"Therapeutic efficacy of a novel selective JAK2 inhibitor (CEP-33779) in organ-specific, autoantibody-induced tissue injury","volume":"2014","author":"Samavedam","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.autrev.2021.102852_bb0690","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12696","article-title":"Tofacitinib as the potent treatment for refractory pemphigus: a possible alternative treatment for pemphigus","volume":"31","author":"Tavakolpour","year":"2018","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.autrev.2021.102852_bb0695","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1001\/jamaophthalmol.2018.3789","article-title":"Treatment of mucous membrane Pemphigoid with Janus kinase inhibitor Baricitinib","volume":"136","author":"Sarny","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.autrev.2021.102852_bb0700","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2018.00201","article-title":"The role of Eosinophils in bullous Pemphigoid: a developing model of eosinophil pathogenicity in Mucocutaneous disease","volume":"5","author":"Amber","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.autrev.2021.102852_bb0705","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.autrev.2019.06.007","article-title":"Epidermolysis bullosa acquisita: a comprehensive review","volume":"18","author":"Kridin","year":"2019","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2021.102852_bb0710","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/1744666X.2016.1221343","article-title":"Clinical features and diagnosis of epidermolysis bullosa acquisita","volume":"13","author":"Vorobyev","year":"2017","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2021.102852_bb0715","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12864-016-2455-2","article-title":"Dissecting genetics of cutaneous miRNA in a mouse model of an autoimmune blistering disease","volume":"17","author":"Gupta","year":"2016","journal-title":"BMC Genomics"},{"key":"10.1016\/j.autrev.2021.102852_bb0720","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1111\/bjd.17840","article-title":"MicroRNA-145-5p regulates fibrotic features of recessive dystrophic epidermolysis bullosa skin fibroblasts","volume":"181","author":"Condorelli","year":"2019","journal-title":"Br J Dermatol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221001245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997221001245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:21:47Z","timestamp":1761600107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997221001245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":144,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S1568997221001245"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102852","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNAs in pemphigus and pemphigoid diseases","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2021.102852","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102852"}}